Private limited company · founded 2020 · active for 6 yearsAkkerplein 7, 3090 Overijse, BelgiumKBO/BCE: BE 0755.383.441
Summary
Flex4Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €30,751 and a net result of €18,711. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 66% of 21,956 sector peers (NACE 47, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
The company's story in a few sentences, from the company register, the Belgian Official Gazette and the filed annual accounts. Each number opens the document the sentence rests on.
On 29 September 2020, Flex4Pharma was incorporated as a private limited company.1Total assets went from €17,300 in 2020 to €59,511 in 2025.2